Name: Dotinurad Tablets (URECE) – 2mg – Low price wholesale comparison - Arizona-mall
Price: 1.00 HKD
Availability: InStock

Dotinurad Tablets (URECE) – 2mg – Low price wholesale comparison

$1.00

Dotinurad Tablets (URECE) contain 2mg of Dotinurad per tablet and are supplied as 28 tablets (14 tablets × 2 blister packs) per box. Manufactured by Japan’s FUJI YAKUHIN CO., LTD., Toyama Plant, and approved by China NMPA (HJ20240164). Intended exclusively for laboratory research purposes on urate metabolism and related disease models. Supports wholesale and retail sales.?Please consult staff for price, other specifications and uses?

Compare

描述

Dotinurad is a selective urate reabsorption inhibitor (SURI) used in research settings to study mechanisms of hyperuricemia and gout. It works by selectively inhibiting URAT1 (urate transporter 1) in the kidneys, reducing serum uric acid levels by enhancing renal urate excretion.

Developed and manufactured by FUJI YAKUHIN CO., LTD., Toyama Plant in Japan, this product is widely utilized in preclinical studies involving urate metabolism, renal function, and anti-gout drug development.

Each tablet contains 2mg of Dotinurad, packaged in two blister packs (14 tablets each) totaling 28 tablets per box. Approved under China NMPA registration number HJ20240164 and product code 86985383000024.

?? For laboratory research use only. Not for human or veterinary use.

Contents hide

1 Dotinurad Tablets Product Specifications

2 Dotinurad Tablets Mechanism & Research Applications

3 Dotinurad Tablets Safety & Handling

4 Research Use Disclaimer

Dotinurad Tablets Product Specifications

Parameter	Details
Product Name	Dotinurad Tablets (URECE)
Generic Name	Dotinurad
CAS Number	1121114-77-3
Molecular Formula	C17H12ClN3O3
Molecular Weight	341.75 g/mol
Dosage Form	Tablet
Strength	2mg per tablet
Quantity	28 tablets (14×2 blister packs)
Approval Number	HJ20240164 (China NMPA)
Product Code	86985383000024
Manufacturer	FUJI YAKUHIN CO., LTD., Toyama Plant (Japan)
Barcode	Not available, contact support
Intended Use	Laboratory research only
Storage Conditions	Store in a cool, dry place, below 25°C

Dotinurad Tablets Mechanism & Research Applications

Selective inhibition of URAT1 (urate transporter 1) to lower serum uric acid
Experimental models of hyperuricemia and gout
Studies on renal urate excretion and urate homeostasis
Preclinical testing of anti-gout and uricosuric drugs
Evaluation of metabolic and renal function changes associated with urate handling

Dotinurad Tablets Safety & Handling

Use Restriction: Strictly for laboratory research; not approved for clinical or veterinary use
Protective Equipment: Gloves, lab coat, and eye protection recommended
Storage: Keep sealed and store below 25°C in a dry place
Disposal: Follow institutional regulations for pharmaceutical waste

Research Use Disclaimer

This product is intended exclusively for laboratory research. It is not certified or approved for clinical, diagnostic, or veterinary use. Improper use may involve health or legal risks. Always comply with local biosafety and research ethics protocols.

其他信息

重量	1 公斤
尺寸	26 × 23 × 26 厘米

评价

目前还没有评价

成为第一个“Dotinurad Tablets (URECE) – 2mg – Low price wholesale comparison” 的评价者

Q1: Is Dotinurad Tablets approved for human use?

A1: No. This product is for laboratory research use only and not approved for clinical or veterinary applications.

Q2: Can I purchase Dotinurad Tablets in bulk?

A2: Yes. We support wholesale and retail orders. Contact us for pricing details.

Q3: Are Certificates of Analysis (COA) and Safety Data Sheets (SDS) available?

A3: Yes. Please request these documents when placing an order.

Q4: What research fields is Dotinurad Tablets suitable for?

A4: It is ideal for urate metabolism studies, gout and hyperuricemia modeling, renal excretion assays, and drug screening.

Q5: What is the packaging format?

A5: The product is supplied as 28 tablets per box, arranged in two blister packs with 14 tablets each.